Xywav 500MG/ML oral solution (SOLN).
Ended Awarded Last action
- Contract number
- 36C26025F0025
- Awardee
-
Jazz Pharmaceuticals, Inc. UEI H9AXCNRA5NE6
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $228,966
Award facts
- Contract value 100% obligated
- $228,966.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Normandy, MO 63121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$81,227 | |
| Original award | $310,193 |
About this award
Jazz Pharmaceuticals, Inc. was awarded a delivery order valued at $228,966.36 by the Veterans Integrated Service Network 20 (VISN 20) for the supply of Xywav 500mg/mL oral solution, a specialty pharmaceutical treatment for narcolepsy and sleep disorders affecting veteran populations. The award, issued on October 1, 2024, is structured as a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. This contract carries no set-aside designation, reflecting unrestricted competitive procurement. The performance location is Normandy, Missouri, and the award is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), which establishes the pricing and terms governing the supply relationship.
This delivery order is issued against Jazz Pharmaceuticals' existing single-award Blanket Purchase Agreement with the Department of Veterans Affairs' National Acquisition Center, valued at $161.2 billion and expiring on August 15, 2026. Jazz Pharmaceuticals serves as the sole prime contractor on this award with no subcontracting arrangements, continuing its established role as a primary supplier of specialty sleep disorder medications to the VA healthcare system. The company, headquartered in Palo Alto, California, has demonstrated sustained federal contracting activity with the VA since 2021, with delivery orders historically ranging from less than $5,000 to over $900,000 across multiple Veterans Integrated Service Networks nationwide.
Quick answers
Who was awarded contract 36C26025F0025?
36C26025F0025 was awarded to Jazz Pharmaceuticals, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C26025F0025 worth?
The government has obligated $228,966 on 36C26025F0025.
Is contract 36C26025F0025 an order under another contract?
Yes. 36C26025F0025 is a delivery order under 36F79719D0205, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0025 competed?
The extent of competition for 36C26025F0025 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award